Please re-read it yourself. Again, nowhere does it say EUA was denied. It says that FDA would not grant it based on EAP data. We have to wait for unblinding of data from full trial.
If you were expecting EUA before data from controlled trial then certainly this might be disappointing, but the writing has been on the wall for quite some role that EUA would not be granted based on uncontrolled EAP data.
The fact that they won’t grant EUA does not reflect negatively on our data. If they agreed to use EAP data then it would have been granted because EAP data looks really really good. They simply want data from full trial, which is still blinded so they can’t make a decision yet.
News 
Market Data 
Discover 
AI
